Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review
K Luttropp, M Dozier, N Justo, F Cornillie, S Kachroo… - BMJ open, 2019 - bmjopen.bmj.com
Objectives To summarise real-world data from studies reporting golimumab persistence in
European immune-mediated rheumatic disease (IMRD) populations and to report pooled …
European immune-mediated rheumatic disease (IMRD) populations and to report pooled …
Real-world patient experience of switching biologic treatment in inflammatory arthritis and ulcerative colitis–a systematic literature review
K Luttropp, J Dalen, A Svedbom, M Dozier… - Patient preference …, 2020 - Taylor & Francis
Purpose To obtain an up-to-date overview of the measurement of patient experience of
switching biologic treatment in patients with inflammatory arthritis (IA) or ulcerative colitis …
switching biologic treatment in patients with inflammatory arthritis (IA) or ulcerative colitis …